Tianjin Yuanshan Medical Technology Co., Ltd. announced that it has entered into capital increase agreement to receive CNY 30,000,000 on January 12, 2024. The transaction included participation from new investors, Tianjin Saixiang Technology Co.,Ltd, for 1.4285% stake and Tianjin Haitai Haihe Biomedical Industry Fund Partnership for 3.3333% stake. Of the total capital increase, CNY 410,600 will be added to registered capital.

The transaction was approved by the board of director of the company at its 13th session of the company?s 8th directorate and the 10th session of the 8th supervisory board of the investor.